Gotham Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-347,015
| Closed | -$1.89M | – | 1627 |
|
|
2024
Q4 | $1.89M | Sell |
347,015
-120,833
| -26% | -$659K | 0.02% | 739 |
|
|
2024
Q3 | $3.89M | Sell |
467,848
-9,796
| -2% | -$81.4K | 0.04% | 562 |
|
|
2024
Q2 | $3.42M | Sell |
477,644
-65,944
| -12% | -$472K | 0.04% | 535 |
|
|
2024
Q1 | $4.71M | Buy |
543,588
+18,675
| +4% | +$162K | 0.07% | 380 |
|
|
2023
Q4 | $3.44M | Buy |
524,913
+900
| +0.2% | +$5.9K | 0.06% | 420 |
|
|
2023
Q3 | $5.24M | Buy |
524,013
+188,420
| +56% | +$1.88M | 0.11% | 239 |
|
|
2023
Q2 | $4.17M | Sell |
335,593
-18,340
| -5% | -$228K | 0.09% | 299 |
|
|
2023
Q1 | $4.96M | Buy |
353,933
+122,524
| +53% | +$1.72M | 0.12% | 202 |
|
|
2022
Q4 | $3.31M | Buy |
231,409
+120,232
| +108% | +$1.72M | 0.09% | 266 |
|
|
2022
Q3 | $2.84M | Sell |
111,177
-20,740
| -16% | -$529K | 0.09% | 285 |
|
|
2022
Q2 | $3.75M | Buy |
131,917
+97,787
| +287% | +$2.78M | 0.12% | 206 |
|
|
2022
Q1 | $1.2M | Buy |
34,130
+15,621
| +84% | +$551K | 0.04% | 509 |
|
|
2021
Q4 | $776K | Buy |
+18,509
| New | +$776K | 0.03% | 620 |
|
|
2021
Q2 | – | Sell |
-6,858
| Closed | -$244K | – | 1060 |
|
|
2021
Q1 | $244K | Buy |
+6,858
| New | +$244K | 0.01% | 893 |
|